SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: EX-99.1 2 v167082_ex99-1.htm
[EX-99.1 2 v167082_ex99-1.htm]
[EX-99.1 2 v167082_ex99-1.htm]
[v167082_ex99-1.htm 2 EX-99.1]
[v167082_ex99-1.htm 2 EX-99.1]
[EX-99.1 2 v166904_ex99-1.htm CERTIFICATE OF CHANGE]
[EX-99.1 2 v166904_ex99-1.htm CERTIFICATE OF CHANGE]
[CERTIFICATE OF CHANGE v166904_ex99-1.htm 2 EX-99.1]
[CERTIFICATE OF CHANGE v166904_ex99-1.htm 2 EX-99.1]
[SKYSTAR BIO-PHARMACEUTICAL COMPANY FORM 10-Q INDEX Page Number PART I. FINANCIAL INFORMATION] [CERTIFICATION I, Weibing Lu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Bennet P. Tchaikovsky, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Weibing Lu Chief Executive Officer EX-32.1 5 v166458_ex32-1.htm] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Bennet P. Tchaikovsky Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 6 v166458_ex32-2.htm]
[SKYSTAR BIO-PHARMACEUTICAL COMPANY FORM 10-Q INDEX Page Number PART I. FINANCIAL INFORMATION] [CERTIFICATION I, Weibing Lu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Bennet P. Tchaikovsky, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Weibing Lu Chief Executive Officer EX-32.1 5 v166458_ex32-1.htm] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Bennet P. Tchaikovsky Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 6 v166458_ex32-2.htm]
[Skystar Bio-Pharmaceutical Company Announces Third Quarter 2009 Financial Results Company Reports Record Quarterly Revenue of $12.78 Million and Adjusted Net Income of $4.25 Million; and Adjusted EPS of $0.61 Per Share XI'AN, CHINA – November 16, 2009 – Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) THIRD QUARTER 2009 HIGHLIGHTS § Revenue increased 27.1% period over period to $12.78 million. § Gross margin]